Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- PMID: 22907116
- DOI: 10.1093/brain/aws189
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
Abstract
The primary progressive form of multiple sclerosis is characterized by accrual of neurological dysfunction from disease onset without remission and it is still a matter of debate whether this disease course results from different pathogenetic mechanisms compared with secondary progressive multiple sclerosis. Inflammation in the leptomeninges has been identified as a key feature of secondary progressive multiple sclerosis and may contribute to the extensive cortical pathology that accompanies progressive disease. Our aim was to investigate the extent of perivascular and meningeal inflammation in primary progressive multiple sclerosis in order to understand their contribution to the pathogenetic mechanisms associated with cortical pathology. A comprehensive immunohistochemical analysis was performed on post-mortem brain tissue from 26 cases with primary progressive multiple sclerosis. A variable extent of meningeal immune cell infiltration was detected and more extensive demyelination and neurite loss in the cortical grey matter was found in cases exhibiting an increased level of meningeal inflammation. However, no tertiary lymphoid-like structures were found. Profound microglial activation and reduction in neuronal density was observed in both the lesions and normal appearing grey matter compared with control cortex. Furthermore, cases with primary progressive multiple sclerosis with extensive meningeal immune cell infiltration exhibited a more severe clinical course, including a shorter disease duration and younger age at death. Our data suggest that generalized diffuse meningeal inflammation and the associated inflammatory milieu in the subarachnoid compartment plays a role in the pathogenesis of cortical grey matter lesions and an increased rate of clinical progression in primary progressive multiple sclerosis.
Similar articles
-
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.Brain. 2011 Sep;134(Pt 9):2755-71. doi: 10.1093/brain/awr182. Epub 2011 Aug 11. Brain. 2011. PMID: 21840891
-
B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis.Brain Pathol. 2020 Jul;30(4):779-793. doi: 10.1111/bpa.12841. Epub 2020 Apr 26. Brain Pathol. 2020. PMID: 32243032 Free PMC article.
-
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.Brain. 2007 Apr;130(Pt 4):1089-104. doi: 10.1093/brain/awm038. Brain. 2007. PMID: 17438020
-
Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models.Immunology. 2021 Nov;164(3):450-466. doi: 10.1111/imm.13395. Epub 2021 Aug 2. Immunology. 2021. PMID: 34293193 Free PMC article. Review.
-
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis.Nat Rev Neurol. 2023 Aug;19(8):461-476. doi: 10.1038/s41582-023-00838-7. Epub 2023 Jul 3. Nat Rev Neurol. 2023. PMID: 37400550 Review.
Cited by
-
The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.Brain Commun. 2024 Oct 9;6(5):fcae359. doi: 10.1093/braincomms/fcae359. eCollection 2024. Brain Commun. 2024. PMID: 39445084 Free PMC article. Review.
-
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.Brain. 2024 Jul 5;147(7):2566-2578. doi: 10.1093/brain/awae030. Brain. 2024. PMID: 38289855
-
Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.Front Immunol. 2022 Feb 1;12:813957. doi: 10.3389/fimmu.2021.813957. eCollection 2021. Front Immunol. 2022. PMID: 35178046 Free PMC article. Review.
-
Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement.Mult Scler Relat Disord. 2019 May;30:136-140. doi: 10.1016/j.msard.2019.02.013. Epub 2019 Feb 11. Mult Scler Relat Disord. 2019. PMID: 30771580 Free PMC article.
-
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis.Biomedicines. 2019 Feb 20;7(1):14. doi: 10.3390/biomedicines7010014. Biomedicines. 2019. PMID: 30791637 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources